{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:59:32Z","timestamp":1785473972328,"version":"3.56.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01552-5","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:27:45Z","timestamp":1785472065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of Primary Hepatic Angiosarcoma: A Comprehensive Review"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3220-2427","authenticated-orcid":false,"given":"Mohsin","family":"Murshid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrar","family":"Nawawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"1552_CR1","unstructured":"Jain SS, Menon G, Samant H. Liver Angiosarcoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026."},{"key":"1552_CR2","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1097\/MS9.0000000000001584","volume":"86","author":"S Rojas","year":"2024","unstructured":"Rojas S, Rey Chaves CE, Robledo S, Conde D, Sabogal Olarte JC. Primary hepatic angiosarcoma: a systematic review. Annals Med Surg. 2024;86:1601\u20135. https:\/\/doi.org\/10.1097\/MS9.0000000000001584.","journal-title":"Annals Med Surg"},{"key":"1552_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.21037\/tcr-20-2780","volume":"10","author":"D Zeng","year":"2021","unstructured":"Zeng D, Zeng X, Duan J, Chen D, Zhu B. Clinical characteristics of primary hepatic angiosarcoma outcomes: a SEER database analysis. Transl Cancer Res. 2021;10:110\u201325. https:\/\/doi.org\/10.21037\/tcr-20-2780.","journal-title":"Transl Cancer Res"},{"key":"1552_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/path.6072","volume":"260","author":"S Huang","year":"2023","unstructured":"Huang S, Chang IY, Chang C, Liu H, Chen K, Liu T, et al. Association between hepatic angiosarcoma and end-stage renal disease: nationwide population\u2010based evidence and enriched mutational signature of aristolochic acid exposure. J Pathol. 2023;260:165\u201376. https:\/\/doi.org\/10.1002\/path.6072.","journal-title":"J Pathol"},{"key":"1552_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.6224","volume":"262","author":"F Chung","year":"2024","unstructured":"Chung F, Zavadil J. New risk factors and molecular landscapes of hepatic angiosarcoma in the Taiwanese population\u2020. J Pathol. 2024;262:1\u20133. https:\/\/doi.org\/10.1002\/path.6224.","journal-title":"J Pathol"},{"key":"1552_CR6","doi-asserted-by":"publisher","first-page":"e2021364","DOI":"10.4322\/acr.2021.364","volume":"12","author":"M Parkhi","year":"2022","unstructured":"Parkhi M, Sekar A. Primary hepatic angiosarcoma in an elderly patient. Autops Case Rep. 2022;12:e2021364. https:\/\/doi.org\/10.4322\/acr.2021.364.","journal-title":"Autops Case Rep"},{"key":"1552_CR7","unstructured":"Herman M, Shi J. Angiosarcoma [Internet]. PathologyOutlines.com. 2026 [cited 2026 June 14]. https:\/\/www.pathologyoutlines.com\/topic\/livertumorangiosarcoma.html. Accessed 14 June 2026."},{"key":"1552_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40792-017-0296-0","volume":"3","author":"Y Yoshida","year":"2017","unstructured":"Yoshida Y, Yoshizumi T, Wang H, Sakata K, Shimokawa M, Kurihara T, et al. Liver transplantation for cryptogenic liver failure caused by diffuse hepatic angiosarcoma: case report. surg case rep. 2017;3:21. https:\/\/doi.org\/10.1186\/s40792-017-0296-0.","journal-title":"surg case rep"},{"key":"1552_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.52604\/alt.22.0020","volume":"2","author":"S-M Kim","year":"2022","unstructured":"Kim S-M, Ahn C-S, Moon D-B, Ha T-Y, Song G-W, Jung D-H, et al. Liver transplantation for primary hepatic angiosarcoma: A report of two cases. Annals of Liver Transplantation. Korean Liver Transplantation Soc. 2022;2:151\u20136. https:\/\/doi.org\/10.52604\/alt.22.0020.","journal-title":"Korean Liver Transplantation Soc"},{"key":"1552_CR10","doi-asserted-by":"publisher","first-page":"1071403","DOI":"10.3389\/fonc.2023.1071403","volume":"13","author":"Y Lin","year":"2023","unstructured":"Lin Y, Chen Z, Yang J, Lin Y, Chen S, Xie Y, et al. Advanced diffuse hepatic angiosarcoma treated successfully with TACE and targeted immunotherapy: A case report. Front Oncol. 2023;13:1071403. https:\/\/doi.org\/10.3389\/fonc.2023.1071403.","journal-title":"Front Oncol"},{"key":"1552_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/aid2.13387","volume":"11","author":"P Wu","year":"2024","unstructured":"Wu P, Kuo H, Sun C, Feng I, Li W, Ho C, et al. Clinical characteristics, imaging features, and outcomes of primary hepatic angiosarcoma: A single-center study and literature review. Adv Dig Med. 2024;11:204\u201314. https:\/\/doi.org\/10.1002\/aid2.13387.","journal-title":"Adv Dig Med"},{"key":"1552_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1623327","author":"HTT Luong","year":"2025","unstructured":"Luong HTT, Vercammen S, de Marco A, de Rooster H, Cosma A. Angiosarcoma: a systematic review of biomarkers in diagnosis, prognosis, and therapeutic strategies. Front Oncol [Internet] Front. 2025. https:\/\/doi.org\/10.3389\/fonc.2025.1623327. [cited 2026 June 14];15.","journal-title":"Front Oncol [Internet] Front"},{"key":"1552_CR13","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.3748\/wjg.v20.i13.3672","volume":"20","author":"Z-B Wang","year":"2014","unstructured":"Wang Z-B. Transcription factor ERG is a specific and sensitive diagnostic marker for hepatic angiosarcoma. WJG. 2014;20:3672. https:\/\/doi.org\/10.3748\/wjg.v20.i13.3672.","journal-title":"WJG"},{"key":"1552_CR14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/1878-0261.13744","volume":"19","author":"A Benton","year":"2025","unstructured":"Benton A, Liu B, Gartenhaus LE, Hanna JA. Genomic landscape and preclinical models of angiosarcoma. Mol Oncol. 2025;19:965\u201383. https:\/\/doi.org\/10.1002\/1878-0261.13744.","journal-title":"Mol Oncol"},{"key":"1552_CR15","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.ejso.2015.04.022","volume":"41","author":"P Chaudhary","year":"2015","unstructured":"Chaudhary P, Bhadana U, Singh R, Ahuja A. Primary hepatic angiosarcoma. Eur J Surg Oncol. 2015;41:1137\u201343. https:\/\/doi.org\/10.1016\/j.ejso.2015.04.022.","journal-title":"Eur J Surg Oncol"},{"key":"1552_CR16","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/annonc\/mdn702","volume":"20","author":"HR Kim","year":"2009","unstructured":"Kim HR, Rha SY, Cheon SH, Roh JK, Park YN, Yoo NC. Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma. Ann Oncol. 2009;20:780\u20137. https:\/\/doi.org\/10.1093\/annonc\/mdn702.","journal-title":"Ann Oncol"},{"key":"1552_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12817-2","volume":"24","author":"L Jiang","year":"2024","unstructured":"Jiang L, Xie L, Wu Z, Ke Q, Chen M, Pan W, et al. Imaging features of hepatic angiosarcoma: retrospective analysis of two centers. BMC Cancer. 2024;24:1191. https:\/\/doi.org\/10.1186\/s12885-024-12817-2.","journal-title":"BMC Cancer"},{"key":"1552_CR18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/COC.0000000000001032","volume":"46","author":"N Ramakrishnan","year":"2023","unstructured":"Ramakrishnan N, Mokhtari R, Charville GW, Bui N, Ganjoo K. Management Strategies and Outcomes in Primary Liver Angiosarcoma. Am J Clin Oncol. 2023;46:439\u201344. https:\/\/doi.org\/10.1097\/COC.0000000000001032.","journal-title":"Am J Clin Oncol"},{"key":"1552_CR19","doi-asserted-by":"publisher","unstructured":"Yi L-L, Zhang J-X, Zhou S-G, Wang J, Huang Y-Q, Li J, et al. CT and MRI studies of hepatic angiosarcoma. Clin Radiol. 2019;74. https:\/\/doi.org\/10.1016\/j.crad.2018.12.013. :406.e1-406.e8.","DOI":"10.1016\/j.crad.2018.12.013"},{"key":"1552_CR20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.91787","volume":"17","author":"Y Shintaro","year":"2025","unstructured":"Shintaro Y, Yasutoshi F, Masataka T, Koji A, Shiro O. Contrast-enhanced ultrasound-guided liver tumor biopsy for primary hepatic angiosarcoma: a case series. Cureus. 2025;17:e91787. https:\/\/doi.org\/10.7759\/cureus.91787.","journal-title":"Cureus"},{"key":"1552_CR21","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.radcr.2025.01.084","volume":"20","author":"CK Crawford","year":"2025","unstructured":"Crawford CK, Arshad H, Chu LC, Fishman EK. Hepatic angiosarcoma: A challenging diagnosis. Radiol Case Rep. 2025;20:2342\u20135. https:\/\/doi.org\/10.1016\/j.radcr.2025.01.084.","journal-title":"Radiol Case Rep"},{"key":"1552_CR22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.87622","volume":"17","author":"E Florou","year":"2025","unstructured":"Florou E, Abarnadevikarthikeyan A, Gregory SM, Srinivasan P, Prachalias A. Angiosarcoma of the liver: a radiological alarm for radiologists and hepato-pancreato-biliary (HPB) surgeons. Cureus. 2025;17:e87622. https:\/\/doi.org\/10.7759\/cureus.87622.","journal-title":"Cureus"},{"key":"1552_CR23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1245\/s10434-018-7062-9","volume":"26","author":"GC Wilson","year":"2019","unstructured":"Wilson GC, Lluis N, Nalesnik MA, Nassar A, Serrano T, Ramos E, et al. Hepatic Angiosarcoma: A Multi-institutional, International Experience with 44 Cases. Ann Surg Oncol. 2019;26:576\u201382. https:\/\/doi.org\/10.1245\/s10434-018-7062-9.","journal-title":"Ann Surg Oncol"},{"key":"1552_CR24","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.3390\/curroncol29050292","volume":"29","author":"A Mangla","year":"2022","unstructured":"Mangla A, Cioffi G, Barnholtz-Sloan JS, Lee RT. Treatment Outcomes for Primary Hepatic Angiosarcoma: National Cancer Database Analysis 2004\u20132014. Current Oncology. Multidisciplinary Digit Publishing Inst. 2022;29:3637\u201346. https:\/\/doi.org\/10.3390\/curroncol29050292.","journal-title":"Multidisciplinary Digit Publishing Inst"},{"key":"1552_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jss.2021.02.043","volume":"264","author":"E Dogeas","year":"2021","unstructured":"Dogeas E, Mokdad AA, Bhattatiry M, Porembka MR, Polanco PM, Mansour JC, et al. Tumor Biology Impacts Survival in Surgically Managed Primary Hepatic Vascular Malignancies. J Surg Res. 2021;264:481\u20139. https:\/\/doi.org\/10.1016\/j.jss.2021.02.043.","journal-title":"J Surg Res"},{"key":"1552_CR26","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.3390\/jcm11112990","volume":"11","author":"S Katou","year":"2022","unstructured":"Katou S, Di Pietro Martinelli C, Silveira C, Schmid F, Becker F, Radunz S, et al. Liver Resection for Primary Hepatic Angiosarcoma: Bicentric Analysis of a Challenging Entity. J Clin Med. 2022;11:2990. https:\/\/doi.org\/10.3390\/jcm11112990.","journal-title":"J Clin Med"},{"key":"1552_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clinre.2017.02.006","volume":"42","author":"M Tran Minh","year":"2018","unstructured":"Tran Minh M, Mazzola A, Perdigao F, Charlotte F, Rousseau G, Conti F. Primary hepatic angiosarcoma and liver transplantation: Radiological, surgical, histological findings and clinical outcome. Clin Res Hepatol Gastroenterol. 2018;42:17\u201323. https:\/\/doi.org\/10.1016\/j.clinre.2017.02.006.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1552_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.18632\/oncoscience.602","volume":"11","author":"GL Guzik","year":"2024","unstructured":"Guzik GL, Mangla A. Primary hepatic angiosarcoma: treatment options for a rare tumor. Oncoscience. 2024;11:47\u20138. https:\/\/doi.org\/10.18632\/oncoscience.602.","journal-title":"Oncoscience"},{"key":"1552_CR29","doi-asserted-by":"publisher","first-page":"11503","DOI":"10.1200\/JCO.2023.41.16_suppl.11503","volume":"41","author":"JE Grilley-Olson","year":"2023","unstructured":"Grilley-Olson JE, Allred JB, Schuetze S, Davis EJ, Wagner MJ, Poklepovic AS, et al. A multicenter phase II study of cabozantinib\u2009+\u2009nivolumab for patients (pts) with advanced angiosarcoma (AS) previously treated with a taxane (Alliance A091902). JCO. 2023;41:11503\u201311503. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.11503.","journal-title":"JCO"},{"key":"1552_CR30","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/cam4.5147","volume":"12","author":"S Watson","year":"2022","unstructured":"Watson S, Verret B, Ropert S, Adam J, Bahleda R, Briand S, et al. Single-agent gemcitabine in patients with advanced, pre\u2010treated angiosarcoma: A multicenter, retrospective study. Cancer Med. 2022;12:3160\u20136. https:\/\/doi.org\/10.1002\/cam4.5147.","journal-title":"Cancer Med"},{"key":"1552_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07199-0","volume":"20","author":"Z Tian","year":"2020","unstructured":"Tian Z, Zhang F, Li P, Wang J, Yang J, Zhang P, et al. Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma. BMC Cancer. 2020;20:698. https:\/\/doi.org\/10.1186\/s12885-020-07199-0.","journal-title":"BMC Cancer"},{"key":"1552_CR32","doi-asserted-by":"publisher","first-page":"11514","DOI":"10.1200\/JCO.2024.42.16_suppl.11514","volume":"42","author":"JE Grilley-Olson","year":"2024","unstructured":"Grilley-Olson JE, Allred JB, Schuetze S, Davis EJ, Poklepovic AS, Wagner MJ, et al. Alliance A091902: A multicenter randomized phase II trial of paclitaxel (P) with or without nivolumab (N) in patients (pts) with advanced angiosarcoma (AS). JCO. 2024;42:11514\u201311514. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.11514.","journal-title":"JCO"},{"key":"1552_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/0284186X.2016.1234068","volume":"56","author":"A Koll\u00e1r","year":"2017","unstructured":"Koll\u00e1r A, Jones RL, Stacchiotti S, Gelderblom H, Guida M, Grignani G, et al. Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis. Acta Oncol. 2017;56:88\u201392. https:\/\/doi.org\/10.1080\/0284186X.2016.1234068.","journal-title":"Acta Oncol"},{"key":"1552_CR34","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1634\/theoncologist.2011-0237","volume":"17","author":"I Ray-Coquard","year":"2012","unstructured":"Ray-Coquard I, Italiano A, Bompas E, Le Cesne A, Robin Y-M, Chevreau C, et al. Sorafenib for Patients with Advanced Angiosarcoma: A Phase II Trial from the French Sarcoma Group (GSF\/GETO). Oncologist. 2012;17:260\u20136. https:\/\/doi.org\/10.1634\/theoncologist.2011-0237.","journal-title":"Oncologist"},{"key":"1552_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12029-024-01157-w","volume":"56","author":"A Wali","year":"2025","unstructured":"Wali A, Robinson J, Iqbal A, Yasinzai AQK, Sohail AH, Jain H, et al. Demographics, Prognostic Factors, and Survival Outcomes in Hepatic Angiosarcoma: A Retrospective Analysis. J Gastrointest Canc. 2025;56:33. https:\/\/doi.org\/10.1007\/s12029-024-01157-w.","journal-title":"J Gastrointest Canc"},{"key":"1552_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12957-015-0489-6","volume":"13","author":"Y-H Lin","year":"2015","unstructured":"Lin Y-H, Lin C-C, Concejero AM, Yong C-C, Kuo F-Y, Wang C-C. Surgical experience of adult primary hepatic sarcomas. World J Surg Onc. 2015;13:87. https:\/\/doi.org\/10.1186\/s12957-015-0489-6.","journal-title":"World J Surg Onc"},{"key":"1552_CR37","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ejso.2020.11.121","volume":"47","author":"S Jiang","year":"2021","unstructured":"Jiang S, Wu H, Lu M, Li N. Surgery and chemotherapy improve the prognosis of primary hepatic angiosarcoma: a retrospective study based on propensity score matched survival analysis. Eur J Surg Oncol. 2021;47:690\u20138. https:\/\/doi.org\/10.1016\/j.ejso.2020.11.121.","journal-title":"Eur J Surg Oncol"},{"key":"1552_CR38","doi-asserted-by":"publisher","unstructured":"Yuan W-H, Li AF-Y, Hsu H-C, Hu Y-S, Lee R-C. Initial clinical radiological findings and staging to predict prognosis of primary hepatic angiosarcoma: A retrospective analysis. Celik H, editor. PLoS ONE. 2019;14:e0225043. https:\/\/doi.org\/10.1371\/journal.pone.0225043","DOI":"10.1371\/journal.pone.0225043"},{"key":"1552_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88703-9","volume":"11","author":"MJ Wagner","year":"2021","unstructured":"Wagner MJ, Lyons YA, Siedel JH, Dood R, Nagaraja AS, Haemmerle M, et al. Combined VEGFR and MAPK pathway inhibition in angiosarcoma. Sci Rep. 2021;11:9362. https:\/\/doi.org\/10.1038\/s41598-021-88703-9.","journal-title":"Sci Rep"},{"key":"1552_CR40","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11864-021-00858-9","volume":"22","author":"V Florou","year":"2021","unstructured":"Florou V, Wilky BA. Current Management of Angiosarcoma: Recent Advances and Lessons From the Past. Curr Treat Options Oncol. 2021;22:61. https:\/\/doi.org\/10.1007\/s11864-021-00858-9.","journal-title":"Curr Treat Options Oncol"},{"key":"1552_CR41","unstructured":"Agenus Inc. A Phase 2 Study Examining AGEN2034 as a Single-Agent and in Combination With AGEN1884 in Patients With Recurrent, Inoperable Angiosarcoma [Internet]. clinicaltrials.gov; 2021 Dec. Report No.: NCT04607200. https:\/\/clinicaltrials.gov\/study\/NCT04607200. Accessed 14 June 2026."}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01552-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01552-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01552-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:27:46Z","timestamp":1785472066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01552-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1552"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01552-5","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"16 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"172"}}